主页
市场
图表与思路
Algo
新闻
Store
经纪商
下载
经济日历
交易信号
网页端
键入
/
进行搜索:@user,$symbol
查找
登录
创建账户
Italiano
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Türkçe
GDTC
#4969
CytoMed Therapeutics Limited Ordinary Shares
1.0
8
+5.88%
版块:
基础:
利润货币:
日范围
年范围
日变化
+5.88%
每月变动
+35.00%
6个月变化
-46.27%
年变化
-59.85%
前一天收盘价
1.0
2
Open
1.0
8
Bid
Ask
Low
1.0
8
High
1.0
8
交易量
1
市场
股票
医疗保健
GDTC
Open full chart
Financials
Overview
声明
Statistics
Dividends
Quarterly
Annual
Income statement
Balance sheet
Cash flow
Value
2022
2023
2024
Total assets
3.9 M
9.38 M
7.37 M
Total liabilities
3.46 M
852.51 K
749.5 K
Total equity
437.4 K
8.52 M
6.62 M
Total liabilities & shareholders' equities
3.9 M
9.38 M
7.37 M
Total debt
—
—
—
Net debt
—
—
—
新闻
Il titolo di CytoMed balza dopo l’annuncio di partnership per trial clinico in Malesia
CytoMed stock jumps after announcing clinical trial partnership in Malaysia
CytoMed Therapeutics enters clinical trial agreement with Malaysian hospital
CytoMed Therapeutics secures $500,000 investment for subsidiary
CytoMed Therapeutics Limited (GDTC) Q2 2025 Earnings Call Prepared Remarks Transcript
CytoMed riporta risultati preclinici promettenti per il trattamento della leucemia
CytoMed reports promising preclinical results for leukemia treatment
CytoMed Therapeutics shareholders approve all proposals at annual meeting
CytoMed Therapeutics schedules annual shareholder meeting